Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Christine A. Ciunci, MD, MSCE

Christine A. Ciunci, MD, MSCE Physician

Interim Chief of Hematology Oncology, Abramson Cancer Center at Penn Presbyterian Medical Center Physician Lead for the Cancer Service Line at Penn Presbyterian Medical Center Assistant Professor of Clinical Medicine

Dr. Ciunci is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2017
  • Internal Medicine, 2011
  • Medical Oncology, 2016

Clinical Expertise:

  • Adenocarcinoma of Lung
  • ALK Translocation
  • Asbestosis
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Cancer of the Mediastinum
  • Chemoradiation
  • Chest Wall Tumors
  • Combined Modality Therapy
  • Diaphragm Tumor
  • EGFR Mutation
  • EGFR Translocation
  • Immunotherapy
  • Inherited Lung Cancer Risk
  • Kras Mutation
  • Large Cell Cancer of the Lung
  • Lung Carcinoid Tumor
  • Lung Lesion
  • Lung Nodule
  • Non-Small Cell Lung Cancer
  • Pleural Cancer
  • RET Mutation
  • ROS1 Fusion
  • Small Cell Lung Cancer
  • Squamous Cancer of the Lung
  • Thoracic Cancer
  • Thymoma and Thymic Carcinoma
  • Thymus Cancer
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Temple University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania


American Society of Clinical Oncology, National

Hospital Affiliation

Dr. Ciunci is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Description of Research Expertise:

thoracic malignancies
lung cancer
head and neck cancer

Selected Publications:

Chao Hann-Hsiang, Berman Abigail T, Simone Charles B, Ciunci Christine, Gabriel Peter, Lin Haibo, Both Stefan, Langer Corey, Lelionis Kristi, Rengan Ramesh, Hahn Stephen M, Prabhu Kiran, Fagundes Marcio, Hartsell William, Mick Rosemarie, Plastaras John P: Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 12 (2): 281-292,2017.

Bagley SJ, Kothari S, Aggarwal C, Bauml JB, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachania A, Langer CJ: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer 106 : 1-7,2017.

Thompson JC1, Yee SS2, Troxel AB3, Savitch SL2, Fan R2, Balli D4, Lieberman DB5, Morrissette JD5, Evans TL6, Bauml J7, Aggarwal C8, Kosteva JA2, Alley E9, Ciunci C2, Cohen RB2, Bagley S2, Stonehouse-Lee S2, Sherry VE2, Gilbert E2, Langer C10, Vachani A11, Carpenter EL12.: Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next generation sequencing of cell-free circulating tumor DNA. Clin Cancer Res 6 : 1231,2016.

Veenstra CM, Vachani A, Ciunci CA, Zafar HM, Epstein AJ, Paulson EC: Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer J Am Coll Radiol 13 (5): 491-6,2016.

Paulson EC, Veenstra CM, Vachani A, Ciunci CA, Epstein AJ: Trends in surveillance for resected colorectal cancer, 2001-2009 Cancer 121 (19): 3525-33,2015.

Veenstra CM, Vachani A, Epstein AJ, Ciunci CA, Zafar HM, Paulson EC: Trends in use of PET imaging in surveillance of lung and colorectal cancer. Journal of Clinical Oncology 33 (suppl; abstr 6563): 2015.

Vachani A, Ciunci C, Veenstra C, Zafar H, Paulson E, Epstein AJ: Trends in use of PET imaging in surveillance of lung cancer: implications of the choosing wisely initiative. Chest : 2015.

Ciunci CA, Paulson EC, Mitra N, Veenstra CM, Yang J, Langer CJ, Epstein AJ, Vachani A: Patterns and effectiveness of surveillance after curative intent surgery in stage I-IIIA non-small cell lung cancer. Journal of Clinical Oncology 33 (suppl; abstr 7546): 2015.

Ciunci CA, Perini RF, Avadhani AN, Kang HC, Sun W, Redlinger M, Harlacker K, Flaherty KT, giantonio B, Rosen MA, Divgi CR, Song HK, Englander S, Troxel A, Schnall M, O'Dwyer PJ: Phase I and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advance cancer Cancer 120 (1): 77-85,2014.

Ciunci CA, Mitra N, Yang L, Langer CJ, DeMichele A, Epstein AJ, Vachani A: Patterns of surveillance after curative intent surgery in elderly stage I-IIIA non-small cell lung cancer patients Journal of Clinical Oncology 32 (suppl; abstr 7541): 2014.

Academic Contact Info

Abramson Cancer Center
Penn Presbyterian Medical Center
Cupp Building 1st Floor
51 N 39th Street

Philadelphia, PA 19104
Phone: (215) 662-9801
Patient appointments: 800-789-7366 (PENN)